Sibrotuzumab (anti-FAP) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183093-1MG / 1MG
CAS No.:216669-97-5
Sibrotuzumab (anti-FAP) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183093-5MG / 5MG
CAS No.:216669-97-5
Dectrekumab (anti-IL-13) Carrier Free, 重組, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183230-100ΜG / 100ΜG
CAS No.:1528523-94-5
Dectrekumab (anti-IL-13) Carrier Free, 重組, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183230-10MG / 10MG
CAS No.:1528523-94-5
Dectrekumab (anti-IL-13) Carrier Free, 重組, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183230-1MG / 1MG
CAS No.:1528523-94-5
Dectrekumab (anti-IL-13) Carrier Free, 重組, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183230-5MG / 5MG
CAS No.:1528523-94-5
Trastuzumab deruxtecan (anti-ERBB2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC)
AB183313-100ΜG / 100ΜG
CAS No.:1826843-81-5
Trastuzumab deruxtecan (anti-ERBB2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC)
AB183313-10MG / 10MG
CAS No.:1826843-81-5
Trastuzumab deruxtecan (anti-ERBB2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC)
AB183313-1MG / 1MG
CAS No.:1826843-81-5
Trastuzumab deruxtecan (anti-ERBB2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC)
AB183313-5MG / 5MG
CAS No.:1826843-81-5
Datopotamab deruxtecan (anti-TROP2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB183314-100ΜG / 100ΜG
CAS No.:2238831-60-0
Datopotamab deruxtecan (anti-TROP2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB183314-10MG / 10MG
CAS No.:2238831-60-0
Datopotamab deruxtecan (anti-TROP2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB183314-1MG / 1MG
CAS No.:2238831-60-0
Datopotamab deruxtecan (anti-TROP2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB183314-5MG / 5MG
CAS No.:2238831-60-0
Patritumab deruxtecan (anti-ERBB3) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB183315-100ΜG / 100ΜG
CAS No.:2227102-46-5
Patritumab deruxtecan (anti-ERBB3) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB183315-10MG / 10MG
CAS No.:2227102-46-5
Patritumab deruxtecan (anti-ERBB3) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB183315-1MG / 1MG
CAS No.:2227102-46-5
Patritumab deruxtecan (anti-ERBB3) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB183315-5MG / 5MG
CAS No.:2227102-46-5
Disitamab vedotin (anti-HER2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB183317-100ΜG / 100ΜG
CAS No.:2136633-23-1
Disitamab vedotin (anti-HER2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB183317-10MG / 10MG
CAS No.:2136633-23-1
Disitamab vedotin (anti-HER2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB183317-1MG / 1MG
CAS No.:2136633-23-1
Disitamab vedotin (anti-HER2) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB183317-5MG / 5MG
CAS No.:2136633-23-1
Iladatuzumab vedotin (anti-CD79b) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB183320-100ΜG / 100ΜG
CAS No.:1906205-77-3
Iladatuzumab vedotin (anti-CD79b) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB183320-10MG / 10MG
CAS No.:1906205-77-3
Iladatuzumab vedotin (anti-CD79b) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB183320-1MG / 1MG
CAS No.:1906205-77-3
Iladatuzumab vedotin (anti-CD79b) ExactAb™, 重組, 已驗證, 無疊氮鈉, 低內毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB183320-5MG / 5MG
CAS No.:1906205-77-3